1. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma
- Author
-
Masanobu Satoh, Toshimitsu Nishijima, Takafumi Nakano, Torahiko Nakashima, Yoshinao Oda, Yui Hatanaka, Satoshi Toh, Hidetaka Yamamoto, Ryuji Yasumatsu, Shizuo Komune, and Hideki Shiratsuchi
- Subjects
0301 basic medicine ,Oncology ,Male ,Time Factors ,Gene Dosage ,Kaplan-Meier Estimate ,Human Papillomavirus DNA Tests ,0302 clinical medicine ,Prevalence ,Medicine ,Papillomaviridae ,Human Papillomavirus DNA Test ,In Situ Hybridization ,Aged, 80 and over ,biology ,HPV infection ,Chemoradiotherapy ,Middle Aged ,Immunohistochemistry ,ErbB Receptors ,Oropharyngeal Neoplasms ,Treatment Outcome ,Head and Neck Neoplasms ,030220 oncology & carcinogenesis ,Carcinoma, Squamous Cell ,Female ,Adult ,medicine.medical_specialty ,DNA Copy Number Variations ,Chromogenic in situ hybridization ,Pathology and Forensic Medicine ,Proto-Oncogene Proteins p21(ras) ,03 medical and health sciences ,Internal medicine ,Biomarkers, Tumor ,Humans ,CISH ,EGFR Protein Overexpression ,Cyclin-Dependent Kinase Inhibitor p16 ,Aged ,Polysomy ,business.industry ,Squamous Cell Carcinoma of Head and Neck ,Papillomavirus Infections ,Gene Amplification ,medicine.disease ,biology.organism_classification ,Head and neck squamous-cell carcinoma ,030104 developmental biology ,DNA, Viral ,Mutation ,business - Abstract
Human papillomavirus (HPV) infection is an indicator of good response to chemoradiotherapy in oropharyngeal squamous cell carcinoma (OPSCC), and epidermal growth factor receptor (EGFR) is a molecular-therapeutic target in head and neck squamous cell carcinoma. Here we investigated the prevalence and prognostic significance of HPV infection and EGFR alteration in OPSCC. We analyzed the presence of high-risk HPV using in situ hybridization, protein expressions of p16 and EGFR using immunohistochemistry, and the EGFR gene copy number gain using chromogenic in situ hybridization (CISH) in 105 cases of OPSCC. The biopsy specimens before chemoradiotherapy were used for these analyses. HPV infection and p16 protein overexpression were detected in 53.3% and 52.4% of the OPSCCs, and each factor was associated with better overall survival (P = .0026 and P = .0026) and nonkeratinizing histology (P = .0002 and P = .0004), respectively. EGFR gene copy number gain (high polysomy or amplification) was detected in 12.4% of the OPSCCs and was correlated with EGFR protein overexpression (P = .0667) and worse overall survival (P < .0001). HPV infection and EGFR gene copy number gain (EGFR CISH positive) were mutually exclusive. The HPV-negative/EGFR CISH-positive OPSCCs had significantly worse overall survival than did the HPV-positive/EGFR CISH-negative OPSCCs and HPV-negative/EGFR CISH-negative OPSCCs (P < .0001 and P < .0001, respectively). The EGFR CISH-negative OPSCCs had favorable prognosis irrespective of HPV infection. Our results suggest that EGFR gene copy number gain-positive tumors represent an HPV-negative, aggressive subgroup of OPSCCs. The molecular subclassification of OPSCCs based on HPV infection and EGFR status may serve as important information for appropriate therapeutic strategy.
- Published
- 2015